Stockreport

Strongbridge Biopharma plc Reports Second Quarter 2019 Financial Results and Provides Corporate Update

Strongbridge Biopharma plc - Ordinary Shares  (SBBP) 
Last strongbridge biopharma plc - ordinary shares earnings: 2/25 07:30 am Check Earnings Report
US:NASDAQ Investor Relations: investors.strongbridgebio.com/investor-overview
PDF ~ KEVEYIS® (dichlorphenamide) Second Quarter 2019 Revenue of $6.1 Million ~ ~ Company on Track to Meet Full-Year 2019 KEVEYIS® Revenue Guidance of $18 to $20 Million ~ [Read more]